NUProtein Co., Ltd. is a Japanese biotechnology company that grows proteins in rice instead of in microbes or animal cells. Its brand OmnivoRice stands for premium proteins from rice, and its stated purpose is to supply growth factors and functional proteins at low cost. Cultivated meat and cellular agriculture are the markets it names.
Plant molecular farming platform
Plant molecular farming means using a crop as a production host for a protein that the plant does not normally make. The company says it uses genetically modified rice grown in enclosed greenhouse conditions. Rice seed is a stable storage organ, so proteins accumulated in grain can be kept dry until extraction.
The site claims a cost reduction of up to 40,000 times for growth factors, which it calls the largest bottleneck in animal cell culture. No baseline or product is named, so the figure is best read as an ambition, and a buyer should ask for the comparison made, such as a price per milligram.
The company says it can supply from research use to commercial production and offers co-development and licensing with partner companies. Licensing means a customer could in principle grow the proteins itself. A cultivated meat producer should decide whether it wants a supplier of finished proteins or a technology partner before starting talks.
Growth factors in cultivated meat
Growth factors are signaling proteins that tell cells to divide or to differentiate. In cultivated meat they are added to the medium, and they can be a large share of medium cost. Common examples are fibroblast growth factor, insulin-like growth factor and transferrin, so a buyer should ask which ones the platform produces.
For readers following cultivated meat and cultivated seafood, the relevant question is whether a plant-made factor is as active as the same protein made in other hosts. Glycosylation, folding and stability differ between hosts. Biological activity should be tested on the cell line in use, with a dose-response series against the current supplier.
Species matters too. A growth factor for chicken or fish cells may need a different sequence from a human one, and a plant host must express that sequence correctly. Ask whether the platform has produced species-specific variants, and request activity data in terms of the dose needed for equivalent growth in the producer’s own cell type.
Rice as a host and food safety
Rice is a staple crop with a long history of food use, which may ease some safety discussions, yet a genetically modified rice line expressing a foreign protein is regulated differently from ordinary rice. The company says its crops are grown in a closed environment, which keeps them separate from field rice.
Purification determines quality. Growth factors must be separated from rice proteins, starch, lipids and phenolics, and residual rice allergens or nucleic acids should be measured. A cultivated meat producer needs a certificate of analysis that states purity, endotoxin level, residual host protein and DNA, and also activity. Ask for the method used for each value and the reference standard.
Another food question is whether any rice-derived residue remains in the medium that reaches the final product. Cells are normally washed and the medium is removed, but regulators judge the entire process, and a dossier will need a full component list. Request a declaration of the origin of every raw material and agree on confidentiality before sharing details.
Evaluation notes
The website is short and offers a contact form for inquiries. A first request should state the protein of interest, the quantity per month, the target purity and the intended market. In reply, ask for a technical data sheet, a sample, a description of the production site and its quality system, and the expected delivery timeline.
Scale and supply are the main commercial risks. Rice grows once or a few times per year, so seed multiplication, harvest timing and storage affect continuity. Ask how many batches the company has produced, what yield per kilogram of grain it reaches and what buffer stock is held for customers who run continuous cultures.
Price comparison should use cost per unit of biological activity, not cost per milligram. A cheaper protein that needs twice the dose or loses activity faster is not cheaper in use. Run a side-by-side culture with the current growth factor, record cell density, viability and differentiation markers over several passages, and compare the total medium cost per kilogram of cells.
Finally, consider the intellectual property position. A platform company with licensing plans should explain freedom to operate, patents covering the host and expression system, and rights to improvements made in joint work. A written term sheet that covers data ownership, exclusivity and supply guarantees protects a small cultivated meat company that depends on a single source for a critical input.